Alloy Therapeutics, Inc.
Biotechnology-Research
Website
Company Tagline
May The Best Drug Win
Industry Category
Business Keywords
Company Description
Alloy Therapeutics, Inc. is a leading biotechnology ecosystem company dedicated to empowering the global scientific community to develop superior medicines through collaboration. Alloy Therapeutics offers access to an expanding range of antibody and bispecific discovery platforms, integrating in vivo and in vitro wet-lab capabilities with advanced AI/ML technologies. These platforms are available through both service partnerships and technology licensing, allowing partners to discover breakthrough biologic medicines. Alloy Therapeutics has collaborated with over 170 partners, including 18 Fortune 50 Biopharmaceutical companies.
Located at 44 Hartwell Ave, Boston, Massachusetts 02421, US, with an additional location at The McClintock Building, Granta Park, Suite 3, Cambridge, CB216GP CB216GP, GB, Alloy Therapeutics is also pioneering advancements in intracellular target engagement with its Keyway™ TCR discovery service. Furthermore, Alloy Therapeutics addresses genetic disease targets with its AntiClastic™ ASO Format, enhancing molecule potency while reducing off-target interactions and inflammatory responses. Alloy Therapeutics also co-builds new biotechnology companies, leveraging its core platforms and service capabilities via its affiliated Venture Studio, 82VS.
Founded in 2017, Alloy Therapeutics reinvests 100% of its revenue into innovation and expanded access to cutting-edge biotechnology solutions. Alloy Therapeutics is committed to making better medicines together with its partners. We invite the manager of Alloy Therapeutics, Inc. to create a customized and exclusive company showcase and product listing on our platform.
Alloy Therapeutics, Inc. est une entreprise leader de l'écosystème biotechnologique, dédiée à donner à la communauté scientifique mondiale les moyens de développer des médicaments de qualité supérieure grâce à la collaboration. Alloy Therapeutics offre l'accès à une gamme croissante de plateformes de découverte d'anticorps et de bispécifiques, intégrant des capacités de laboratoire humide in vivo et in vitro avec des technologies avancées d'IA/ML. Ces plateformes sont disponibles à la fois par le biais de partenariats de service et de licences de technologie, permettant aux partenaires de découvrir des médicaments biologiques révolutionnaires. Alloy Therapeutics a collaboré avec plus de 170 partenaires, dont 18 entreprises biopharmaceutiques du classement Fortune 50.
Situé au 44 Hartwell Ave, Boston, Massachusetts 02421, États-Unis, avec un emplacement supplémentaire au The McClintock Building, Granta Park, Suite 3, Cambridge, CB216GP CB216GP, GB, Alloy Therapeutics est également pionnier dans les avancées de l'engagement de cibles intracellulaires avec son service de découverte Keyway™ TCR. De plus, Alloy Therapeutics aborde les cibles de maladies génétiques avec son format ASO AntiClastic™, améliorant la puissance de la molécule tout en réduisant les interactions hors cible et les réponses inflammatoires. Alloy Therapeutics co-construit également de nouvelles sociétés de biotechnologie, tirant parti de ses plateformes de base et de ses capacités de service via son Venture Studio affilié, 82VS.
Fondée en 2017, Alloy Therapeutics réinvestit 100 % de ses revenus dans l'innovation et l'accès élargi aux solutions biotechnologiques de pointe. Alloy Therapeutics s'engage à fabriquer de meilleurs médicaments avec ses partenaires. Nous invitons le responsable d'Alloy Therapeutics, Inc. à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme.
Key Personnel / Employees
Compare Companies Side by Side
Compare Alloy Therapeutics, Inc. with 3 companies in Biotechnology-Research
| Comparison Field |
Alloy Therapeutics, Inc.Main Company |
Anthem Biosciences P...View Profile |
BioNTech SEView Profile |
Chimeric Therapeutic...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2006 | 2008 | 2020 |
|
Company Size
|
— | 1,001-5,000 | 1,001-5,000 | 2-10 |
|
City
|
Boston, Massachusetts | Bangalore, Karnataka | Mainz, Rhineland-Palatinate | Carlton, Victoria |
|
Country
|
United States | India | Germany | Australia |
|
Skills & Keywords
Comparing with main company
|
18 Total Skills
Biologics Discovery
Drug Discovery
Biotechnology
Antibody Discovery
Biopharmaceutical
Therapeutic Modalities
Genetic Disease Targets
RNA
Company Creation
Bispecific Antibodies
Chimeric Antigen Receptors
ASO
TCR
Monoclonal Antibodies
Venture Studios
Biotech
Immunotherapy
Humanized Transgenic Mouse
|
9 Total
9 Unique
Unique Skills:
Agriculture Chemicals
Biology
Bio-Pharma
Chemistry
Contract Research Organization
CRO
+3
|
12 Total
12 Unique
Unique Skills:
Antibody therapeutics
Bispecific antibodies
CAR T
Cell therapy
Individualized cancer medicine
Infectious diseases
+6
|
5 Total
5 Unique
Unique Skills:
Cancer Research
Cell Therapy
drug development
Immunooncology
Life Sciences
|
4
Total Companies2006
Oldest Founded4
Countries44
Unique SkillsSimilar Companies
Other organizations in the same industry
hylabs (Hy Laboratories Ltd)
Biotechnology-ResearchDeveloper, manufacturer and distributor of detection and identifi...
Bountica
Biotechnology-ResearchFood-safe & nature-based functional proteins that help protect perishable foods and beverages
Activatec Ltd
Biotechnology-ResearchTechnology development, R&D, Biobased ingredients
Alternative Company Names
This company is also known as